We’re excited to announce our latest financing as we look to further develop our product offering, expand our customer base and continue in our journey to help the pharmaceutical supply chain to digitise.
Bringing on investors with expertise across digital, pharmaceuticals, logistics and technology is exciting and will ensure we can continue to deliver value to our customers. These include ex-head of Corporate Strategy for Microsoft, Charlie Songhurst, EVP of Operations at Vectura Group and previous VP of Global Supply Chain at Baxter, Tony Fitzpatrick and Antonin de Fougerolles, CEO of Evox Therapeutics in addition to leading VC funds, Force Over Mass, Seedcamp, Ascension Ventures, Plug and Play, Blockchain Valley Ventures, and Truesight Ventures.
We’re delighted to continue to support Veratrak. Having led their previous funding round, we’ve been impressed with the progress they’ve achieved in a short period of time and excited for what the future holds post this round of funding. There is a clear need for more innovative solutions to solve numerous inefficiencies across the pharmaceutical supply chain. We firmly believe that Veratrak’s platform is ideally positioned to provide users at multiple stakeholders in this massive market the solution they are in need of.